Opioid dependence and abuse are prevalent and continue to be a concern in our society and the workers’ compensation population. Medication-assisted treatment using methadone, buprenorphine, or naltrexone along with counseling and other support is one of the options for managing opioid use disorder. Analyzing the trends within our data related to these types of medications can provide valuable additional insight into the prevalence of evidence-based and guideline-supported approaches related to overall opioid strategy. Watch the video blog to learn more.
More stories
WorkCompWire
News Release
Jill Harris: For Workers’ Comp Industry, Navigating Provider Shortage Requires Fresh Thinking
Enlyte
Article
Top Auto Casualty Trends to Watch in 2022
The year 2021 brought new challenges to the auto insurance industry—from frequent shifts in miles driven to significant staffing shortages.
Workers' Comp
Article
Workers’ Compensation: 2022 Trends & Predictions
As we enter 2022 still mired in the COVID-19 pandemic, the workers’ compensation industry faces another challenging year, with payers continuing to
Workers' Comp
Article
P&C Industry Claims Severity: Trends, Drivers and Mitigators
Claim severity has always been top of mind for the P&C industry.
Watch Now
CE Webinar
Common Foot & Ankle Injuries in the Workplace
On-Demand
Foot and ankle injuries are common in workers’ compensation claims.
Mitchell
News Release
Opioid Addiction Drug Buprenorphine Increases Risk of Dental Issues According to FDA
The Food and Drug Administration (FDA) recently issued a warning concerning the risk of dental p